204 related articles for article (PubMed ID: 24285837)
1. Targeting CD137 enhances vaccine-elicited anti-respiratory syncytial virus CD8+ T cell responses in aged mice.
Lee S; Mittler RS; Moore ML
J Immunol; 2014 Jan; 192(1):293-9. PubMed ID: 24285837
[TBL] [Abstract][Full Text] [Related]
2. Vaccine-elicited CD8+ T cells protect against respiratory syncytial virus strain A2-line19F-induced pathogenesis in BALB/c mice.
Lee S; Stokes KL; Currier MG; Sakamoto K; Lukacs NW; Celis E; Moore ML
J Virol; 2012 Dec; 86(23):13016-24. PubMed ID: 23015695
[TBL] [Abstract][Full Text] [Related]
3. A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.
Lambert SL; Aslam S; Stillman E; MacPhail M; Nelson C; Ro B; Sweetwood R; Lei YM; Woo JC; Tang RS
PLoS One; 2015; 10(3):e0119509. PubMed ID: 25793508
[TBL] [Abstract][Full Text] [Related]
4. The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia.
Olson MR; Hartwig SM; Varga SM
J Immunol; 2008 Dec; 181(11):7958-68. PubMed ID: 19017987
[TBL] [Abstract][Full Text] [Related]
5. CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease.
Olson MR; Varga SM
J Immunol; 2007 Oct; 179(8):5415-24. PubMed ID: 17911628
[TBL] [Abstract][Full Text] [Related]
6. Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8
Lee JY; Chang J
J Microbiol; 2017 Nov; 55(11):900-908. PubMed ID: 29076066
[TBL] [Abstract][Full Text] [Related]
7. Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.
Cyr SL; Jones T; Stoica-Popescu I; Brewer A; Chabot S; Lussier M; Burt D; Ward BJ
Vaccine; 2007 Jul; 25(29):5378-89. PubMed ID: 17561317
[TBL] [Abstract][Full Text] [Related]
8. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
[TBL] [Abstract][Full Text] [Related]
9. Inferior immunogenicity and efficacy of respiratory syncytial virus fusion protein-based subunit vaccine candidates in aged versus young mice.
Cayatte C; Snell Bennett A; Rajani GM; Hostetler L; Maynard SK; Lazzaro M; McTamney P; Ren K; O'Day T; McCarthy MP; Schneider-Ohrum K
PLoS One; 2017; 12(11):e0188708. PubMed ID: 29182682
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary eosinophilia is attenuated by early responding CD8(+) memory T cells in a murine model of RSV vaccine-enhanced disease.
Stevens WW; Sun J; Castillo JP; Braciale TJ
Viral Immunol; 2009 Jul; 22(4):243-51. PubMed ID: 19594395
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of STAT6 during vaccination with formalin-inactivated RSV prevents induction of Th2-cell-biased airway disease.
Srinivasa BT; Fixman ED; Ward BJ
Eur J Immunol; 2014 Aug; 44(8):2349-59. PubMed ID: 24796717
[TBL] [Abstract][Full Text] [Related]
12. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T
Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice.
Boyoglu-Barnum S; Chirkova T; Todd SO; Barnum TR; Gaston KA; Jorquera P; Haynes LM; Tripp RA; Moore ML; Anderson LJ
J Virol; 2014 Sep; 88(18):10569-83. PubMed ID: 24990999
[TBL] [Abstract][Full Text] [Related]
14. Gene-gun DNA vaccination aggravates respiratory syncytial virus-induced pneumonitis.
Bartholdy C; Olszewska W; Stryhn A; Thomsen AR; Openshaw PJM
J Gen Virol; 2004 Oct; 85(Pt 10):3017-3026. PubMed ID: 15448365
[TBL] [Abstract][Full Text] [Related]
15. Agonistic 4-1BB antibody fails to reduce disease burden during acute respiratory syncytial virus (RSV) infection.
Norris MJ; Duan W; Cen Y; Moraes TJ
Antiviral Res; 2016 Jan; 125():46-50. PubMed ID: 26597692
[TBL] [Abstract][Full Text] [Related]
16. Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines.
Crowe JE; Firestone CY; Murphy BR
J Immunol; 2001 Oct; 167(7):3910-8. PubMed ID: 11564809
[TBL] [Abstract][Full Text] [Related]
17. Enhanced humoral and CD8+ T cell immunity in mice vaccinated by DNA vaccine against human respiratory syncytial virus through targeting the encoded F protein to dendritic cells.
Hua Y; Jiao YY; Ma Y; Peng XL; Fu YH; Zhang XJ; Zheng YB; Zheng YP; Hong T; He JS
Int Immunopharmacol; 2017 May; 46():62-69. PubMed ID: 28259002
[TBL] [Abstract][Full Text] [Related]
18. Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infection.
Muralidharan A; Russell M; Larocque L; Gravel C; Li C; Chen W; Cyr T; Lavoie JR; Farnsworth A; Rosu-Myles M; Wang L; Li X
Sci Rep; 2018 Nov; 8(1):16648. PubMed ID: 30413743
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease.
Jorquera PA; Choi Y; Oakley KE; Powell TJ; Boyd JG; Palath N; Haynes LM; Anderson LJ; Tripp RA
PLoS One; 2013; 8(9):e74905. PubMed ID: 24040360
[TBL] [Abstract][Full Text] [Related]
20. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.
Cimica V; Boigard H; Bhatia B; Fallon JT; Alimova A; Gottlieb P; Galarza JM
Clin Vaccine Immunol; 2016 Jun; 23(6):451-9. PubMed ID: 27030590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
